FDA-Device2017-03-01Class II
Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing.
Tosoh Bioscience, Inc.
Hazard
The device defect associated with this recall may result in HbA1c values with a negative bias in patients with the hemoglobin variants C, D, E and S. The negative bias occurs at the higher levels of HbA1c, e.g. 9%, but not at the diagnostic medical decision point of 6.5%.
Sold states
Worldwide distribution. The products were shipped to the following states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, AND WY. The recalled products were shipped to the following countries: Brazil, Chile, Columbia, Guatemala, Costa Rica, Dominican Republic, Eduador, Nicaragua, Panama, Peru, Puerto Rico, Uruguay,
Affected count
682 analyzers
Manufactured in
6000 Shoreline Ct Ste 101, N/A, South San Francisco, CA, United States
Products
Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1225-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief